News

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...
A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...
A US judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and ...
A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes ...
April 24 - A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge ...
Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...
Highlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent ...
A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...
An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...